01/20/2026
Immunomic Therapeutics Announces FDA Clearance of IND Application for a UNITE®-Based Self-Amplifying RNA Vaccine for Triple-Negative Breast Cancer. For more information, read the full press release here: https://ow.ly/PKCx50Y0eBY
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneeri
15010 Broschart Road Ste 250
Rockville, MD
20850
Be the first to know and let us send you an email when Immunomic Therapeutics, Inc posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Immunomic Therapeutics, Inc: